Delhi HC gives Biocon, Mylan green light to market blockbuster biosimilar for three cancers

— March 3, 2017 comments off

The court’s latest move, which allows the companies to use Roche’s product data in their package inserts, is expected to allow Biocon and Mylan to grab more revenue.